Literature DB >> 2293574

Epinephrine synthesis by an N-methyltransferase in rat liver.

H Elayan1, B Kennedy, M G Ziegler.   

Abstract

We investigated if liver can synthesize epinephrine in vitro and in vivo. Homogenates of rat liver readily synthesized [3H]epinephrine from [3H]S-adenosylmethionine and norepinephrine. Liver homogenates also N-methylated dopamine at more than twice the rate that they N-methylated norepinephrine. In contrast, adrenal homogenates, which N-methylate norepinephrine to form epinephrine using the enzyme phenylethanolamine-N-methyltransferase (PNMT), methylated dopamine only about 1% as well as norepinephrine. Synthesis of epinephrine by liver homogenates was not significantly inhibited by the PNMT inhibitor SKF 29661 at a concentration that inhibited adrenal homogenate epinephrine synthesis by nearly 90%. These findings indicate that liver can synthesize epinephrine in vitro using an enzyme other than PNMT. Adrenal demedullation of rats reduced plasma epinephrine levels to 7% of control values, but left liver epinephrine and epinephrine-forming enzyme levels unchanged. Treatment of demedullated rats with 6-hydroxydopamine plus reserpine also resulted in dramatically reduced plasma epinephrine levels but no change in hepatic epinephrine and N-methylating enzyme levels. We conclude that the liver synthesizes its own epinephrine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293574     DOI: 10.1016/0016-5085(90)91304-o

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  2 in total

1.  Differential control of glycogenolysis and flow by arterial and portal acetylcholine in perfused rat liver.

Authors:  A Gardemann; H Beck; K Jungermann
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

Review 2.  The Role of Catecholamines in Pathophysiological Liver Processes.

Authors:  Elise Lelou; Anne Corlu; Nicolas Nesseler; Claudine Rauch; Yannick Mallédant; Philippe Seguin; Caroline Aninat
Journal:  Cells       Date:  2022-03-17       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.